The DOI matches its Crossref record; 35 of the 36 references it cites were found in a registry or an index.
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Open accessAbstract
Current genome-editing technologies introduce double-stranded (ds) DNA breaks at a target locus as the first step to gene correction. Although most genetic diseases arise from point mutations, current approaches to point mutation correction are inefficient and typically induce an abundance of random insertions and deletions (indels) at the target locus resulting from the cellular response to dsDNA breaks. Here we report the development of 'base editing', a new approach to genome editing that enables the direct, irreversible conversion of one target DNA base into another in a programmable manner, without requiring dsDNA backbone cleavage or a donor template. We engineered fusions of CRISPR/Cas9 and a cytidine deaminase enzyme that retain the ability to be programmed with a guide RNA, do not induce dsDNA breaks, and mediate the direct conversion of cytidine to uridine, thereby effecting a C→T (or G→A) substitution. The resulting 'base editors' convert cytidines within a window of approximately five nucleotides, and can efficiently correct a variety of point mutations relevant to human disease. In four transformed human and murine cell lines, second- and third-generation base editors that fuse uracil glycosylase inhibitor, and that use a Cas9 nickase targeting the non-edited strand, manipulate the cellular DNA repair response to favour desired base-editing outcomes, resulting in permanent correction of ~15-75% of total cellular DNA with minimal (typically ≤1%) indel formation. Base editing expands the scope and efficiency of genome editing of point mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An alternative approach is to use CRISPR-Cas9 coupled to DNA editing enzymes that catalyze targeted A-to-G or Cto-T genomic sequence changes without inducing a break in DNA, potentially reversing pathogenic single-nucleotide changes or disabling genes via the introduction of a stop codon 25,26 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Base editors are one such tool, which couple Cas9 nickases with nucleotide deaminases to achieve single nucleotide conversion without introducing DSBs.”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The discovery of spontaneous hydrolytic deamination of cytosine converting C-G base pairs to T-A in humans highlighted the potential of base editing for direct base pair conversion without requiring double-strand breaks or homology repair templates (Komor, et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor, et al., 2016
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Next-generation CRISPR tools, such as base editors, use enzymes like cytidine or adenine deaminases fused to Cas9 to introduce single nucleotide variants (SNVs) without DSBs.12,13”
From Protocol to create isogenic disease models from adult stem cell-derived organoids using next-generation CRISPR tools (2024) · cites this paper as [12]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the same paper, with enhanced third-generation base editors, Komor et al. achieved >30-fold greater editing efficiency in various human cell lines when compared to HDR-mediated Cas9 editing, with fewer indel formation.”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
Experimental — accuracy not yet measured
The cited source says what the claim attributes to it.
In the citing paper
“Alternatives to DNA cleavage-induced editing include using CRISPR-Cas9 for direct chemical sequence alteration (base editing) 25,26 , providing RNA templates for gene alteration (prime editing) 27,28 , and for transcriptional control (CRISPR interference, CRISPRi; CRISPR activation, CRISPRa) 29,30 (Fig. 3).”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“CBE converts cytosine to thymine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“First-generation base editors had limitations such as low efficiency and base excision repair (BER) activity that reversed edits (Komor et al., 2016).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Second-generation editors, such as APOBEC-XTEN-dCas9-UGI, added an uracil DNA glycosylase inhibitor (UGI) to improve C-to-T conversion (Komor et al., 2016) but still had <0.1% indel formation, limiting precision (Azameti and Dauda, 2021).”
From Emerging applications of gene editing technologies for the development of climate-resilient crops (2025) · cites this paper as Komor et al., 2016
The cited source says what the claim attributes to it.
In the citing paper
“Fusion of a cytidine deaminase (rAPOBEC1) to a partially inactive nickase-Cas9(D10A) protein results in a cytidine base editor (CBE) that allows for C > T base changes via a uracil intermediate28”
From One-step generation of tumor models by base editor multiplexing in adult stem cell-derived organoids (2023) · cites this paper as [28]
The cited source says what the claim attributes to it.
In the citing paper
“Coupling this Cas9n or dCas9, the catalytically “dead” variant of Cas9, with a cytidine deaminase enzyme enables the gRNA-mediated deamination of cytosine (C) bases in the non-target DNA strand into uracil (U), which shares the base-pairing properties of thymine (T) [82].”
From CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool (2019) · cites this paper as [82]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The second study used CRISPR-Cas9-mediated genome editing to remove a mutation in exon 23 in the mdx mouse model of DMD, providing partial recovery of functional dystrophin protein in skeletal myofibers and cardiac muscle 25,26,49 .”
From The promise and challenge of therapeutic genome editing (2020) · cites this paper as [25]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“ABE catalyzes the editing from adenine to guanine”
From Off-target effects in CRISPR/Cas9 gene editing (2023) · cites this paper as Komor et al., 2016
Experimental — accuracy not yet measuredIn the citing paper
“Variations on these methods enable the functional evaluation of genes (via knockout screens124), regulatory elements (using CRISPR interference and CRISPR activation screens125,126), and genetic variants (base editors127) at increasing scale and resolution29.”
From A brief history of human disease genetics (2020) · cites this paper as [127]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
Shrestha, S., & Offer, S. M. (2016) · Medical Epigenetics · doi:10.1159/000444713 · Cited by 8,951
CRISPR-Cas systems for editing, regulating and targeting genomes
Sander, J. D., & Joung, J. K. (2014) · Nature Biotechnology · doi:10.1038/nbt.2842 · Cited by 3,153
ClinVar: public archive of interpretations of clinically relevant variants
Landrum, M. J., Lee, J. M., Benson, M., Brown, G., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Hoover, J., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1222 · Cited by 2,758
High-fidelity CRISPR-Cas9 nucleases with no detectable genome-wide off-target effects
Kleinstiver, B. P., Pattanayak, V., Prew, M. S., Tsai, S. Q., Nguyen, N. T., Zheng, Z., & Joung, J. K. (2016) · Nature · doi:10.1038/nature16526 · Cited by 2,673
Rationally engineered Cas9 nucleases with improved specificity
Slaymaker, I. M., Gao, L., Zetsche, B., Scott, D. A., Yan, W. X., & Zhang, F. (2016) · Science · doi:10.1126/science.aad5227 · Cited by 2,414
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
Tsai, S. Q., Zheng, Z., Nguyen, N. T., Liebers, M., Topkar, V. V., Thapar, V., Wyvekens, N., Khayter, C., Iafrate, A. J., Le, L. P., et al. (2015) · Nature Biotechnology · doi:10.1038/nbt.3117 · Cited by 2,268
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752
Cited by
Sorted by citations
Items 401–500 of 1,035
Loureiro, A., & da Silva, G. J. (2019) · Antibiotics · doi:10.3390/antibiotics8010018 · Cited by 129
Targeted mutagenesis in mouse cells and embryos using an enhanced prime editor
Park, S.-J., Jeong, T. Y., Shin, S. K., Yoon, D. E., Lim, S.-Y., Kim, S. P., Choi, J., Lee, H., Hong, J.-I., Ahn, J., et al. (2021) · Genome biology · doi:10.1186/s13059-021-02389-w · Cited by 133
An engineered ScCas9 with broad PAM range and high specificity and activity
Chatterjee, P., Jakimo, N., Lee, J., Amrani, N., Rodríguez, T., Koseki, S., Tysinger, E., Qing, R., Hao, S., Sontheimer, E. J., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0517-0 · Cited by 131
Recent progress in translational engineered in vitro models of the central nervous system
Nikolakopoulou, P., Rauti, R., Voulgaris, D., Shlomy, I., Maoz, B. M., & Herland, A. (2020) · Brain · doi:10.1093/brain/awaa268 · Cited by 133
Mitochondrial base editor induces substantial nuclear off-target mutations
Lei, Z., Meng, H., Liu, L., Zhao, H., Rao, X., Yan, Y., Wu, H., Liu, M., He, A., & Yi, C. (2022) · Nature · doi:10.1038/s41586-022-04836-5 · Cited by 131
Biotechnological Advances to Improve Abiotic Stress Tolerance in Crops
Villalobos-López, M. Á., Arroyo-Becerra, A., Quintero-Jiménez, A., & Iturriaga, G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231912053 · Cited by 129
Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease
Lebek, S., Chemello, F., Caravia, X. M., Tan, W. H., Li, H. Z., Chen, K., Xu, L., Liu, N., Bassel‐Duby, R., & Olson, E. N. (2023) · Science · doi:10.1126/science.ade1105 · Cited by 129
Implications of human genetic variation in CRISPR-based therapeutic genome editing
Scott, D. A., & Zhang, F. (2017) · Nature Medicine · doi:10.1038/nm.4377 · Cited by 129
Editing the microbiome the CRISPR way
Ramachandran, G., & Bikard, D. (2019) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2018.0103 · Cited by 130
Adenine base editors catalyze cytosine conversions in human cells
Kim, H. S., Jeong, Y. K., Hur, J. K., Kim, J., & Bae, S. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0254-4 · Cited by 127
Genome editing in large animals: current status and future prospects
Zhao, J., Lai, L., Ji, W., & Zhou, Q. (2019) · National Science Review · doi:10.1093/nsr/nwz013 · Cited by 129
Dead Cas Systems: Types, Principles, and Applications
Brezgin, S., Kostyusheva, A., Kostyushev, D. S., & Chulanov, V. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20236041 · Cited by 135
Massively parallel kinetic profiling of natural and engineered CRISPR nucleases
Jones, S. K., Hawkins, J. A., Johnson, N. V., Jung, C., Hu, K., Rybarski, J. R., Chen, J. S., Doudna, J. A., Press, W. H., & Finkelstein, I. J. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0646-5 · Cited by 131
CRISPR/dCas9-Based Systems: Mechanisms and Applications in Plant Sciences
Karlson, C. K. S., Noor, S. N. M., Nolte, N., & Tan, B. C. (2021) · Plants · doi:10.3390/plants10102055 · Cited by 139
Multiplex genome-editing technologies for revolutionizing plant biology and crop improvement
Abdelrahman, M., Wei, Z., Rohila, J. S., & Zhao, K. (2021) · Frontiers in Plant Science · doi:10.3389/fpls.2021.721203 · Cited by 125
Engineering Introns to Express RNA Guides for Cas9- and Cpf1-Mediated Multiplex Genome Editing
Ding, D., Chen, K., Chen, Y., Li, H., & Xie, K. (2018) · Molecular Plant · doi:10.1016/j.molp.2018.02.005 · Cited by 125
The NIH Somatic Cell Genome Editing program
Saha, K., Sontheimer, E. J., Brooks, P. J., Dwinell, M. R., Gersbach, C. A., Liu, D. R., Murray, S. A., Tsai, S. Q., Wilson, R. C., Anderson, D. G., et al. (2021) · Nature · doi:10.1038/s41586-021-03191-1 · Cited by 127
Self-citationAdvances in gene therapy hold promise for treating hereditary hearing loss
Jiang, L., Wang, D., He, Y., & Shu, Y. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.02.001 · Cited by 125
A new age of precision gene therapy
Schambach, A., Buchholz, C. J., Torres-Ruiz, R., Cichutek, K., Morgan, M. A., Trapani, I., & Büning, H. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01952-9 · Cited by 135
Precise Editing at DNA Replication Forks Enables Multiplex Genome Engineering in Eukaryotes
Barbieri, E. M., Muir, P., Akhuetie‐Oni, B. O., Yellman, C. M., & Isaacs, F. J. (2017) · Cell · doi:10.1016/j.cell.2017.10.034 · Cited by 126
Modrzejewski, D., Hartung, F., Sprink, T., Krause, D., Kohl, C., & Wilhelm, R. (2019) · Environmental Evidence · doi:10.1186/s13750-019-0171-5 · Cited by 134
Expanding the CRISPR Toolbox in Zebrafish for Studying Development and Disease
Liu, K., Petree, C., Requena, T., Varshney, P., & Varshney, G. K. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00013 · Cited by 139
Sequence-specific prediction of the efficiencies of adenine and cytosine base editors
Song, M., Kim, H. K., Lee, S., Kim, Y., Seo, S.-Y., Park, J., Choi, J. W., Jang, H., Shin, J. H., Min, S., et al. (2020) · Nature Biotechnology · doi:10.1038/s41587-020-0573-5 · Cited by 125
Self-citationSOAT1 promotes mevalonate pathway dependency in pancreatic cancer
Oni, T. E., Biffi, G., Baker, L. A., Yuan, H., Tonelli, C., Somerville, T. D. D., Deschênes, A., Belleau, P., Hwang, C., Rivera, F. J. S., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20192389 · Cited by 126
CRISPR–Cas9-based genetic engineering for crop improvement under drought stress
Sami, A., Zhao, X., Tazein, S., Arshad, A., Zhu, Z., Chen, Y., Hong, Y., Zhu, X. T., & Zhou, K. (2021) · Bioengineered · doi:10.1080/21655979.2021.1969831 · Cited by 124
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Belgrad, J., Fakih, H. H., & Khvorova, A. (2024) · Nucleic Acid Therapeutics · doi:10.1089/nat.2023.0068 · Cited by 130
Base editing in plants: Current status and challenges
Bharat, S. S., Li, S., Li, J., Yan, L., & Xia, L. (2019) · The Crop Journal · doi:10.1016/j.cj.2019.10.002 · Cited by 126
Prime Editing in the model plant Physcomitrium patens and its potential in the tetraploid potato
Perroud, P., Guyon‐Debast, A., Veillet, F., Kermarrec, M.-P., Chauvin, L., Chauvin, J.-É., Gallois, J., & Nogué, F. (2021) · Plant Science · doi:10.1016/j.plantsci.2021.111162 · Cited by 130
Massively parallel base editing to map variant effects in human hematopoiesis
Martin-Rufino, J. D., Castano, N., Pang, M., Grody, E. I., Joubran, S. R., Caulier, A., Wahlster, L., Li, T., Qiu, X., Riera-Escandell, A. M., et al. (2023) · Cell · doi:10.1016/j.cell.2023.03.035 · Cited by 130
Self-citationSingle-Nucleotide-Resolution Computing and Memory in Living Cells
Farzadfard, F., Gharaei, N., Higashikuni, Y., Jung, G., Cao, J., & Lu, T. K. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.07.011 · Cited by 122
Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
Rees, H. A., Yeh, W.-H., & Liu, D. R. (2019) · Nature Communications · doi:10.1038/s41467-019-09983-4 · Cited by 129
Self-citationEfficient base editing for multiple genes and loci in pigs using base editors
Xie, J., Ge, W., Li, N., Liu, Q., Chen, F., Yang, X., Huang, X., Ouyang, Z., Zhang, Q., Zhao, Y., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10421-8 · Cited by 127
CRISPR-Based Gene Therapies: From Preclinical to Clinical Treatments
Laurent, M., Geoffroy, M., Pavani, G., & Guiraud, S. (2024) · Cells · doi:10.3390/cells13100800 · Cited by 126
Kluesner, M. G., Lahr, W. S., Lonetree, C.-L., Smeester, B. A., Qiu, X., Slipek, N. J., Claudio Vázquez, P. N., Pitzen, S. P., Pomeroy, E. J., Vignes, M. J., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-22009-2 · Cited by 121
Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation
Mahas, A., Neal Stewart, C., & Mahfouz, M. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.008 · Cited by 110
Sürün, D., Schneider, A., Mircetic, J., Neumann, K., Lansing, F., Paszkowski‐Rogacz, M., Hänchen, V., Lee‐Kirsch, M. A., & Buchholz, F. (2020) · Genes · doi:10.3390/genes11050511 · Cited by 129
A Cas9 with PAM recognition for adenine dinucleotides
Chatterjee, P., Lee, J., Nip, L., Koseki, S., Tysinger, E., Sontheimer, E. J., Jacobson, J. M., & Jakimo, N. (2020) · Nature Communications · doi:10.1038/s41467-020-16117-8 · Cited by 126
CRISPR artificial splicing factors
Du, M., Jillette, N., Zhu, J. J., Li, S., & Cheng, A. W. (2020) · Nature Communications · doi:10.1038/s41467-020-16806-4 · Cited by 127
Genome editing for plant research and crop improvement
Zhan, X., Lu, Y., Zhu, J., & Botella, J. R. (2020) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13063 · Cited by 121
Genome editing and its applications in genetic improvement in aquaculture
Yang, Z., Yu, Y., Tay, Y. X., & Yue, G. H. (2021) · Reviews in Aquaculture · doi:10.1111/raq.12591 · Cited by 122
BE-PLUS: a new base editing tool with broadened editing window and enhanced fidelity
Jiang, W., Feng, S., Huang, S., Yu, W., Li, G., Yang, G., Liu, Y., Zhang, Y., Zhang, L., Hou, Y., et al. (2018) · Cell Research · doi:10.1038/s41422-018-0052-4 · Cited by 120
CRISPR-Based Crop Improvements: A Way Forward to Achieve Zero Hunger
Ahmad, S., Tang, L., Shahzad, R., Mawia, A. M., Rao, G. S., Jamil, S., Chen, W., Sheng, Z., Shao, G., Wei, X., et al. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c02653 · Cited by 125
Emerging genetic therapy for sickle cell disease
Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119
Review of gene therapies for age-related macular degeneration
Khanani, A. M., Thomas, M. J., Aziz, A. A., Weng, C. Y., Danzig, C. J., Yiu, G., Kiss, S., Waheed, N. K., & Kaiser, P. K. (2022) · Eye · doi:10.1038/s41433-021-01842-1 · Cited by 119
CRISPR/Cas9-mediated noncoding RNA editing in human cancers
Yang, J., Meng, X., Pan, J., Jiang, N., Zhou, C., Wu, Z., & Gong, Z. (2017) · RNA Biology · doi:10.1080/15476286.2017.1391443 · Cited by 122
Improving drought tolerance in rice: Ensuring food security through multi‐dimensional approaches
Khan, M. I. R., Palakolanu, S. R., Chopra, P., Rajurkar, A. B., Gupta, R., Iqbal, N., & Maheshwari, C. (2020) · Physiologia Plantarum · doi:10.1111/ppl.13223 · Cited by 119
Tieu, V., Sotillo, E., Bjelajac, J. R., Chen, C., Malipatlolla, M. B., Guerrero, J. A., Xu, P., Quinn, P. J., Fisher, C., Klysz, D. D., et al. (2024) · Cell · doi:10.1016/j.cell.2024.01.035 · Cited by 122
Chow, R. D.-W., & Chen, S. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.03.002 · Cited by 122
Applications of CRISPR-Cas Enzymes in Cancer Therapeutics and Detection
Huang, C., Lee, K.-C., & Doudna, J. A. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.05.006 · Cited by 119
Overcoming bottlenecks in plant gene editing
Atkins, P., & Voytas, D. F. (2020) · Current Opinion in Plant Biology · doi:10.1016/j.pbi.2020.01.002 · Cited by 124
Plant Genome Editing and the Relevance of Off-Target Changes
Graham, N. D., Patil, G., Bubeck, D. M., Dobert, R. C., Glenn, K. C., Gutsche, A. T., Kumar, S., Lindbo, J. A., Maas, L., May, G. D., et al. (2020) · PLANT PHYSIOLOGY · doi:10.1104/pp.19.01194 · Cited by 120
PE-Designer and PE-Analyzer: web-based design and analysis tools for CRISPR prime editing
Hwang, G., Jeong, Y. K., Habib, O., Hong, S.-A., Lim, K., Kim, J., & Bae, S. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab319 · Cited by 122
Present and future prospects for wheat improvement through genome editing and advanced technologies
Li, S., Zhang, C., Li, J., Yan, L., Wang, N., & Xia, L. (2021) · Plant Communications · doi:10.1016/j.xplc.2021.100211 · Cited by 118
Generation and characterization of stable pig pregastrulation epiblast stem cell lines
Zhi, M., Zhang, J., Tang, Q., Yu, D., Gao, S., Gao, D., Liu, P., Guo, J., Hai, T., Gao, J., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00592-9 · Cited by 122
CRISPR Modeling and Correction of Cardiovascular Disease
Liu, N., & Olson, E. N. (2022) · Circulation Research · doi:10.1161/circresaha.122.320496 · Cited by 120
Millen, R., de Kort, W. W. B., Koomen, M., van Son, G. J. F., Gobits, R., de Vries, B. B. L. P., Begthel, H., Zandvliet, M. M. J. M., Doornaert, P., Raaijmakers, C. P. J., et al. (2023) · Med · doi:10.1016/j.medj.2023.04.003 · Cited by 130
Genome editing by natural and engineered CRISPR-associated nucleases
Wu, W. Y., Lebbink, J. H. G., Kanaar, R., Geijsen, N., & John van der, O. O. S. T. (2018) · Nature Chemical Biology · doi:10.1038/s41589-018-0080-x · Cited by 119
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
Abdelnour, S. A., Xie, L., Hassanin, A. A., Zuo, E., & Lu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699597 · Cited by 121
Automating the design-build-test-learn cycle towards next-generation bacterial cell factories
Gurdo, N., Volke, D. C., McCloskey, D., & Nikel, P. I. (2023) · New Biotechnology · doi:10.1016/j.nbt.2023.01.002 · Cited by 121
Rivera, F. J. S., Diaz, B. J., Kastenhuber, E. R., Schmidt, H., Katti, A., Kennedy, M. C., Tem, V., Ho, Y.-J., Leibold, J., Paffenholz, S. V., et al. (2022) · Nature Biotechnology · doi:10.1038/s41587-021-01172-3 · Cited by 117
Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies
Wienert, B., Martyn, G. E., Funnell, A. P. W., Quinlan, K. G. R., & Crossley, M. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.09.004 · Cited by 115
Cas9-induced large deletions and small indels are controlled in a convergent fashion
Kosicki, M., Allen, F., Steward, F., Tomberg, K., Pan, Y., & Bradley, A. (2022) · Nature Communications · doi:10.1038/s41467-022-30480-8 · Cited by 115
Challenges in delivery systems for CRISPR-based genome editing and opportunities of nanomedicine
Sioson, V. A., Kim, M., & Joo, J. (2021) · Biomedical Engineering Letters · doi:10.1007/s13534-021-00199-4 · Cited by 120
Huang, T. P., Heins, Z., Miller, S. M., Wong, B. G., Balivada, P. A., Wang, T., Khalil, A. S., & Liu, D. R. (2022) · Nature Biotechnology · doi:10.1038/s41587-022-01410-2 · Cited by 120
Self-citationTools for efficient genome editing; ZFN, TALEN, and CRISPR
Shamshirgaran, Y., Liu, J., Sumer, H., Verma, P. J., & Taheri-Ghahfarokhi, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2301-5_2 · Cited by 114
Genome editing for horticultural crop improvement
Xu, J., Hua, K., & Lang, Z. (2019) · Horticulture Research · doi:10.1038/s41438-019-0196-5 · Cited by 117
The Role of Noncoding Variants in Heritable Disease
French, J. D., & Edwards, S. L. (2020) · Trends in Genetics · doi:10.1016/j.tig.2020.07.004 · Cited by 128
Ex vivo cell-based CRISPR/Cas9 genome editing for therapeutic applications
Li, Y., Glass, Z., Huang, M., Chen, Z., & Xu, Q. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2019.119711 · Cited by 118
Carotenoid biofortification in crop plants: citius, altius, fortius
Zheng, X., Giuliano, G., & Al‐Babili, S. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2020.158664 · Cited by 116
Genome Editing Technologies for Rice Improvement: Progress, Prospects, and Safety Concerns
Zafar, K., Sedeek, K. E. M., Rao, G. S., Khan, M. Z., Amin, I. U., Kamel, R., Mukhtar, Z., Zafar, M., Mansoor, S., & Mahfouz, M. M. (2020) · Frontiers in Genome Editing · doi:10.3389/fgeed.2020.00005 · Cited by 113
CRISPR/Cas9 gene editing in legume crops: Opportunities and challenges
Bhowmik, P., Konkin, D. J. F., Polowick, P. L., Hodgins, C. L., Subedi, M., Xiang, D., Yu, B., Patterson, N. A., Rajagopalan, N., Babic, V., et al. (2021) · Legume Science · doi:10.1002/leg3.96 · Cited by 113
Enhancement of prime editing via xrRNA motif-joined pegRNA
Zhang, G., Liu, Y., Huang, S., Qu, S., Cheng, D., Yao, Y., Ji, Q., Wang, X., Huang, X., & Liu, J. (2022) · Nature Communications · doi:10.1038/s41467-022-29507-x · Cited by 117
Allogeneic CAR-T Therapy Technologies: Has the Promise Been Met?
Lonez, C., & Breman, E. (2024) · Cells · doi:10.3390/cells13020146 · Cited by 119
Editing the Genome Without Double-Stranded DNA Breaks
Komor, A. C., Badran, A. H., & Liu, D. R. (2017) · ACS Chemical Biology · doi:10.1021/acschembio.7b00710 · Cited by 112
Self-citationThe CRISPR /Cas revolution reaches the RNA world: Cas13, a new Swiss Army knife for plant biologists
Wolter, F., & Puchta, H. (2018) · The Plant Journal · doi:10.1111/tpj.13899 · Cited by 113
Class 2 CRISPR/Cas: an expanding biotechnology toolbox for and beyond genome editing
Tang, Y., & Fu, Y. (2018) · Cell & Bioscience · doi:10.1186/s13578-018-0255-x · Cited by 121
Harnessing Genome Editing Techniques to Engineer Disease Resistance in Plants
Mushtaq, M., Sakina, A., Wani, S. H., Shikari, A. B., Tripathi, P., Zaid, A., Galla, A., Abdelrahman, M., Sharma, M., Singh, A. K., et al. (2019) · Frontiers in Plant Science · doi:10.3389/fpls.2019.00550 · Cited by 113
Sheep and Goat Genome Engineering: From Random Transgenesis to the CRISPR Era
Kalds, P., Zhou, S., Cai, B., Liu, J., Wang, Y., Petersen, B., Sonstegard, T. S., Wang, X., & Chen, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00750 · Cited by 114
Strategies to Increase On-Target and Reduce Off-Target Effects of the CRISPR/Cas9 System in Plants
Hajiahmadi, Z., Movahedi, A., Wei, H., Li, D., Orooji, Y., Ruan, H., & Zhuge, Q. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153719 · Cited by 112
Li, Y., Zhu, J., Wu, H., Liu, C., Huang, C., Lan, J., Zhao, Y., & Xie, C. (2019) · The Crop Journal · doi:10.1016/j.cj.2019.10.001 · Cited by 112
Target base editing in soybean using a modified CRISPR/Cas9 system
Cai, Y., Chen, L., Zhang, Y., Yuan, S., Su, Q., Sun, S., Wu, C., Yao, W., Han, T., & Hou, W. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13386 · Cited by 113
Schenke, D., & Cai, D. (2020) · iScience · doi:10.1016/j.isci.2020.101478 · Cited by 116
Breeding and biotechnological interventions for trait improvement: status and prospects
Singh, R. K., Prasad, A., Muthamilarasan, M., Parida, S. K., & Prasad, M. (2020) · Planta · doi:10.1007/s00425-020-03465-4 · Cited by 112
The Development of Herbicide Resistance Crop Plants Using CRISPR/Cas9-Mediated Gene Editing
Dong, H., Huang, Y., & Wang, K. (2021) · Genes · doi:10.3390/genes12060912 · Cited by 121
Increasing the efficiency and precision of prime editing with guide RNA pairs
Zhuang, Y., Liu, J., Wu, H., Zhu, Q., Yan, Y., Meng, H., Chen, P. R., & Yi, C. (2021) · Nature Chemical Biology · doi:10.1038/s41589-021-00889-1 · Cited by 112
CRISPR-based therapeutics: current challenges and future applications
Modell, A. E., Lim, D., Nguyen, T. M., Sreekanth, V., & Choudhary, A. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.10.012 · Cited by 114
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposase
Witte, I. P., Lampe, G. D., Eitzinger, S., Miller, S. M., Berríos, K. N., McElroy, A. N., King, R. T., Stringham, O. G., Gelsinger, D. R., Vo, P. L. H., et al. (2025) · Science · doi:10.1126/science.adt5199 · Cited by 121
Self-citationGene therapy: a double-edged sword with great powers
Tang, R., & Xu, Z. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03834-3 · Cited by 117
Editing the genome of hiPSC with CRISPR/Cas9: disease models
Bassett, A. R. (2017) · Mammalian Genome · doi:10.1007/s00335-017-9684-9 · Cited by 125
Humanising the mouse genome piece by piece
Zhu, F., Nair, R., Fisher, E., & Cunningham, T. J. (2019) · Nature Communications · doi:10.1038/s41467-019-09716-7 · Cited by 114
Sharpening the Molecular Scissors: Advances in Gene-Editing Technology
Broeders, M., Herrero-Hernandez, P., Ernst, M. P. T., van der Ploeg, A. T., & Pijnappel, W. W. M. P. (2019) · iScience · doi:10.1016/j.isci.2019.100789 · Cited by 114
Chemical modifications of adenine base editor mRNA and guide RNA expand its application scope
Jiang, T., Henderson, J. M., Coote, K. J., Cheng, Y., Valley, H. C., Zhang, X.-O., Wang, Q., Rhym, L. H., Cao, Y., Newby, G. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15892-8 · Cited by 112
Self-citationCas12a Base Editors Induce Efficient and Specific Editing with Low DNA Damage Response
Wang, X., Ding, C., Yu, W., Wang, Y., He, S., Yang, B., Xiong, Y., Wei, J., Li, J., Liang, J., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107723 · Cited by 110
Potato Virus X Vector-Mediated DNA-Free Genome Editing in Plants
Ariga, H., Toki, S., & Ishibashi, K. (2020) · Plant and Cell Physiology · doi:10.1093/pcp/pcaa123 · Cited by 110
Bioengineered Enzymes and Precision Fermentation in the Food Industry
Boukid, F., Ganeshan, S., Wang, Y., Tulbek, M. C., & Nickerson, M. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241210156 · Cited by 110
Cell-specific CRISPR–Cas9 activation by microRNA-dependent expression of anti-CRISPR proteins
Hoffmann, M. D., Aschenbrenner, S., Große, S., Rapti, K., Domenger, C., Fakhiri, J., Mastel, M., Börner, K., Eils, R., Grimm, D., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz271 · Cited by 112
Pramanik, D., Shelake, R. M., Kim, M. J., & Kim, J. (2020) · Molecular Plant · doi:10.1016/j.molp.2020.11.002 · Cited by 110
Efficient precise in vivo base editing in adult dystrophic mice
Xu, L. M., Zhang, C., Bailin, P. L., Wang, P., Gao, Y., Mohler, P. J., Mokadam, N. A., Ma, J., Arnold, W. D., & Han, R. (2021) · Nature Communications · doi:10.1038/s41467-021-23996-y · Cited by 118
Simplified adenine base editors improve adenine base editing efficiency in rice
Hua, K., Tao, X., Liang, W., Zhang, Z., Gou, R., & Zhu, J. (2020) · Plant Biotechnology Journal · doi:10.1111/pbi.13244 · Cited by 108
Precision genome engineering through adenine and cytosine base editing
Kim, J. (2018) · Nature Plants · doi:10.1038/s41477-018-0115-z · Cited by 109
Metadata
- Authors
- Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R.
- Affiliations
- Howard Hughes Medical Institute (US)
- Corresponding author
- Liu, David R.
- Venue
- Nature
- Published
- 2016-04-20
- Volume
- 533
- Issue
- 7603
- Pages
- 420-424
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4873371
- OpenAlex
- W2336828812
- Cited by
- 5,437
- References
- 36
- Citations by year
- 2026: 564 · 2025: 660 · 2024: 664 · 2023: 719 · 2022: 681 · 2021: 614 · 2020: 540 · 2019: 408 · 2018: 338 · 2017: 182 · 2016: 61
- FWCI
- 171.45
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Institute of General Medical Sciences (T32GM008313, F32 GM 106601-2, F32GM106601, F32 GM 112366-2, R01GM065400, F32GM112366)
- National Institute of Biomedical Imaging and Bioengineering (R01EB022376)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- base editing, CRISPR/Cas9, cytidine deaminase, point mutation correction, Cas9 nickase, DNA repair, guide RNA, genome editing, human disease models
- MeSH terms
- APOBEC-1 Deaminase, RNA, Guide, CRISPR-Cas Systems, Animals, Base Sequence, Cell Line, Cytidine, Cytidine Deaminase, Deoxyribonuclease I, DNA, DNA Repair, Genetic Engineering, Humans, Templates, Genetic, Uridine, Genes, p53, Genome, Point Mutation, Mice, Uracil-DNA Glycosidase, Apolipoprotein E4, DNA Cleavage, INDEL Mutation, Clustered Regularly Interspaced Short Palindromic Repeats, CRISPR-Cas Systems, CRISPR-Associated Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
